Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
Sanara MedTech (Nasdaq: SMTI) said company management will present at the Piper Sandler 37th Annual Healthcare Conference in New York, running December 2–4, 2025. Management will deliver a presentation to investors on Wednesday, December 3 at ~9:30 a.m. Eastern Time. Presentation materials will be posted to the company’s investor relations website prior to the talk. A live audio webcast will be accessible under the Events section of the investor relations site, and an archive will be available for replay after the conference.
Sanara MedTech (Nasdaq: SMTI) ha comunicato che la direzione dell’azienda parteciperà alla Piper Sandler 37th Annual Healthcare Conference a New York, dal 2 al 4 dicembre 2025. La direzione terrà una presentazione agli investitori mercoledì 3 dicembre alle ~9:30 ora orientale. I materiali della presentazione saranno pubblicati sul sito dedicato alle relazioni con gli investitori prima dell’intervento. Una webcast audio in diretta sarà accessibile nella sezione Events del sito delle relazioni con gli investitori, e un archivio sarà disponibile per la riproduzione dopo la conferenza.
Sanara MedTech (Nasdaq: SMTI) informó que la dirección de la empresa presentará en la Piper Sandler 37th Annual Healthcare Conference en Nueva York, del 2 al 4 de diciembre de 2025. La dirección ofrecerá una presentación a los inversores el miércoles 3 de diciembre a las ~9:30 a.m. hora del Este. Los materiales de la presentación se publicarán en el sitio de relaciones con inversores antes de la intervención. Una transmisión de audio en vivo estará disponible bajo la sección Events del sitio de relaciones con inversores, y habrá un archivo disponible para su reproducción después de la conferencias.
Sanara MedTech (나스닥: SMTI)은 회사 경영진이 뉴욕에서 열리는 Piper Sandler 37th Annual Healthcare Conference에 참석하여 2025년 12월 2일부터 4일까지 발표할 예정이라고 발표했습니다. 경영진은 투자자들에게 동부 표준시 기준 12월 3일 수요일 오전 약 9시 30분에 발표를 진행합니다. 발표 자료는 발표 전에 회사의 투자자 관계 웹사이트에 게시됩니다. 라이브 오디오 생중계는 투자자 관계 사이트의 Events 섹션에서 이용 가능하며, 컨퍼런스 이후 재생을 위한 아카이브도 제공됩니다.
Sanara MedTech (Nasdaq : SMTI) a indiqué que la direction de l’entreprise participera à la Piper Sandler 37th Annual Healthcare Conference à New York, du 2 au 4 décembre 2025. La direction fera une présentation aux investisseurs le mercredi 3 décembre vers 9h30 environ, heure de lêst. Les supports de présentation seront publiés sur le site des relations investisseurs avant l’intervention. Une diffusion audio en direct sera disponible dans la section Events du site des relations investisseurs, et une archive sera disponible pour réécouter après la conférence.
Sanara MedTech (Nasdaq: SMTI) gab bekannt, dass das Management des Unternehmens an der Piper Sandler 37th Annual Healthcare Conference in New York teilnehmen wird, vom 2. bis 4. Dezember 2025. Das Management wird den Investoren am Mittwoch, dem 3. Dezember, gegen 9:30 Uhr Eastern Time eine Präsentation geben. Die Präsentationsmaterialien werden vor dem Vortrag auf der Investor-Relations-Website des Unternehmens veröffentlicht. Eine Live-Audio-Übertragung ist im Bereich Events der Investor-Relations-Seite zugänglich, und ein Archiv steht nach der Konferenz zur erneuten Wiedergabe zur Verfügung.
Sanara MedTech (ناسداك: SMTI) ذكرت أن إدارة الشركة ستعرض في مؤتمر Piper Sandler السنوي الثالث والثلاثين للرعاية الصحية في نيويورك، في 2–4 ديسمبر 2025. ستقدِّم الإدارة عرضاً للمستثمرين يوم الأربعاء 3 ديسمبر نحو الساعة 9:30 صباحاً بتوقيت المنطقة الشرقية. ستُنشر مواد العرض على موقع علاقات المستثمرين الخاص بالشركة قبل الحديث. سيكون هناك بث صوتي مباشر متاح ضمن قسم Events من موقع علاقات المستثمرين، كما سيكون أرشيف قابل لإعادة التشغيل بعد انتهاء المؤتمر.
- None.
- None.
FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that management will participate in the Piper Sandler 37th Annual Healthcare Conference, which is being held at The Lotte New York Palace in New York, NY from December 2 – 4, 2025. Management will deliver a presentation to investors on Wednesday, December 3 at approximately 9:30 a.m. Eastern Time.
The presentation materials for the conference will be posted to the Company’s investor relations website, https://sanaramedtech.com/investor-relations/, prior to the presentation. A live audio webcast of the presentation will also be accessible under the “Events” section of the Company’s investor relations website at https://sanaramedtech.com/investor-relations/. An archive of the webcast will be available for replay following the conference.
About Sanara MedTech Inc.
Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. The Company develops, markets, and distributes surgical products for use by physicians and clinicians in hospitals. Each of the Company’s products, services, and technologies are designed to achieve the goal of providing better clinical outcomes at a lower overall cost for patients. Sanara’s products are primarily sold in the North American surgical tissue repair markets. Sanara markets and distributes CellerateRX® Surgical Activated Collagen® Powder, BIASURGE® Advanced Surgical Solution, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, as well as a portfolio of advanced biologic products including: ACTIGEN® Verified Inductive Bone Matrix, ALLOCYTE® Plus Advanced Viable Bone Matrix, BiFORM® Bioactive Moldable Matrix, and TEXAGEN® Amniotic Membrane Allograft to the surgical market. The Company believes it can drive its pipeline from concept to preclinical and clinical development while meeting quality and regulatory requirements. The Company strives to be one of the most innovative and comprehensive providers of effective surgical solutions and is continually seeking to expand its offerings for patients requiring treatments in the United States. For more information, please visit SanaraMedTech.com.
Information about Forward-Looking Statements
The statements in this press release that do not constitute historical facts are “forward-looking statements,” within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, among others, statements regarding the Company’s ability to improve its operating efficiency, the Company’s business strategy and mission, the development of new products, the timing of commercialization of the Company’s products, the regulatory approval process and expansion of the Company’s business into value-based skin, wound care and other services. These items involve risks, contingencies and uncertainties such as uncertainties associated with the development and process for obtaining regulatory approval for new products, the Company’s ability to build out its executive team, the Company’s ability to identify and effectively utilize the net proceeds of the CRG Term Loan Agreement to support the Company’s growth initiatives, the extent of product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, uncertainties associated with the development and process for obtaining regulatory approval for new products, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company’s SEC filings, which could cause the Company’s actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements.
All forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of these statements to reflect future circumstances or the occurrence of unanticipated events, except as required by applicable securities laws.
Investor Relations Contact:
Jack Powell or Mike Piccinino, CFA
ICR Healthcare
IR@sanaramedtech.com
FAQ
When will Sanara MedTech (SMTI) present at the Piper Sandler Healthcare Conference?
Where is the Piper Sandler 37th Annual Healthcare Conference being held for Sanara MedTech (SMTI)?
How can investors access Sanara MedTech (SMTI) presentation materials for the December 3, 2025 presentation?
Will there be a webcast of Sanara MedTech’s (SMTI) Piper Sandler conference presentation?
Where on the web can I find the Sanara MedTech (SMTI) conference replay after December 4, 2025?
